Huda Y. Zoghbi

Companies

• Regeneron PharmaceuticalsBoard member Sep 12, 2016 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Regeneron Pharmaceuticals REGN1,703 shares²$1.4M at $806.51Aug 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 10, 2026Sold 800 shares at $800.00 of Regeneron Pharmaceuticals²
• Aug 10, 2026Exercised options 800 shares at $376.69 of Regeneron Pharmaceuticals²
• Feb 19, 2026Sold 4 shares at $790.00 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 56 shares at $785.61 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 160 shares at $784.45 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 220 shares at $783.29 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 298 shares at $782.10 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 209 shares at $781.28 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 331 shares at $780.45 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 208 shares at $779.55 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 53 shares at $778.47 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 50 shares at $775.50 of Regeneron Pharmaceuticals³
• Feb 19, 2026Sold 49 shares at $774.68 of Regeneron Pharmaceuticals³
• Feb 19, 2026Exercised options 1,638 shares at $376.69 of Regeneron Pharmaceuticals³
• Jan 2, 2026Granted 155 shares of Regeneron Pharmaceuticals⁴
• Jan 2, 2025Granted 166 shares of Regeneron Pharmaceuticals⁵
• Jan 2, 2024Granted 135 shares of Regeneron Pharmaceuticals⁶
• Jan 2, 2024Sold 1,117 shares at $900.00 of Regeneron Pharmaceuticals⁶
• Jan 2, 2024Exercised options 1,117 shares at $391.92 of Regeneron Pharmaceuticals⁶
• Oct 13, 2023Sold 1,000 shares at $850.00 of Regeneron Pharmaceuticals⁷
• Oct 13, 2023Exercised options 1,000 shares at $391.92 of Regeneron Pharmaceuticals⁷
• Jan 3, 2023Granted 165 shares of Regeneron Pharmaceuticals⁸
• Mar 16, 2022Sold 2,000 shares at $675.00 of Regeneron Pharmaceuticals⁹
• Mar 16, 2022Exercised options 2,000 shares at $391.92 of Regeneron Pharmaceuticals⁹
• Jan 3, 2022Granted 191 shares of Regeneron Pharmaceuticals¹⁰